#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13810	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2191	626.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1809	1809	T	751	T	693	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13810	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2191	626.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1543	1543	C	771	C,A	719,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25498	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3578	710.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1638	1638	A	896	A	829	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25498	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3578	710.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2272	2272	C	815	C	751	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25498	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3578	710.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2346	2346	A	800	A	744	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25498	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3578	710.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2898	2898	C	776	C,T	396,340	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	45606	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1511	3003.0	0	.	p	.	0	P12S	NONSYN	34	36	CCC	300	302	TCC	3830;3844;3866	T;C,G;C,T	3554;3556,1;3576,1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	G5V	NONSYN	13	15	GGT	387	389	GTT	94;93;94	G;T;T	92;90;92	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	408	410	AAA	114;118;119	A;A;A	108;112;114	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	465	467	TTG	159;159;161	T;T;G	151;152;154	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	498	500	CAA	193;192;193	C;A;A	182;180;178	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	S75P	NONSYN	223	225	TCC	597	599	CCT	178;177;180	C;C;T	164;167;171	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	V87A	NONSYN	259	261	GTA	633	635	GCA	187;184;183	G;C;A	177;173;170	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	V130L	NONSYN	388	390	GTC	762	764	CTC	189;190;190	C;T;C	173;174;178	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	R135C	NONSYN	403	405	CGC	777	779	TGT	199;194;188	T;G;T	183;182;171	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	T137A	NONSYN	409	411	ACG	783	785	GCG	191;190;186	G;C,G;G	181;175,1;173	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	825	827	AAG	178;178;177	A;A;G	169;168;169	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	828	830	AAT	179;176;175	A;A;T	171;167;167	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1026	1028	TTG	141;141;138	T;T;G	133;134;130	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1056	1058	AGC	128;124;123	A;G;C	123;118;116	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1125	1127	CTG	105;106;106	C;T;G	97;100;100	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1131	1133	TCC	106;106;103	T;C;C	100;96;95	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1146	1148	GTG	116;117;115	G;T;G	111;108;109	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1640	folP	852	852	93.78	folP.l15.c4.ctg.1	1535	106.3	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1197	1199	GCG	150;151;148	G;C;G	136;137;135	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5024	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3415	146.5	1	SNP	p	S91F	0	.	.	271	273	TCC	576	578	TCC	180;179;180	T;C;C,T	170;167;169,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5024	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3415	146.5	1	SNP	p	D95N	0	.	.	283	285	GAC	588	590	GAC	178;176;175	G;A;C	166;163;164	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5024	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3415	146.5	1	SNP	p	D95G	0	.	.	283	285	GAC	588	590	GAC	178;176;175	G;A;C	166;163;164	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1568	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1257	124.2	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	651	651	T	187	T	170	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	868	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1014	85.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1452	1454	ATC	195;198;195	A,G;T;C	181,1;180;179	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1605	1607	GCA	204;207;206	G,A;C,T;A	188,1;191,1;191	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	1	SNP	p	D86N	0	.	.	256	258	GAC	558	560	GAC	191;190;189	G;A;C	181;181;179	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	1	SNP	p	S87I	0	.	.	259	261	AGT	561	563	AGT	190;191;191	A;G;T	184;182;182	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	1	SNP	p	S87W	0	.	.	259	261	AGT	561	563	AGT	190;191;191	A;G;T	184;182;182	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	1	SNP	p	S87R	0	.	.	259	261	AGT	561	563	AGT	190;191;191	A;G;T	184;182;182	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4994	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2953	168.3	1	SNP	p	S88P	0	.	.	262	264	TCC	564	566	TCC	190;190;192	T,C;C;C,A	180,1;180;183,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4336	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2662	162.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	201;204;202	G;G;C,A	181;183;177,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1231	1233	GCA	201;196;199	G,A;C;A,C	178,1;172;176,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1234	1236	ATC	199;201;203	A;T;C,G	177;180;178,1	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1246	1248	GTG	196;191;191	G;T;G	177;172;173	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1246	1248	GTG	196;191;191	G;T;G	177;172;173	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1750	1752	ACC	213;211;211	A;C;C	189;195;197	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1804	1806	GCG	213;212;212	G;C;G	194;173;188	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1804	1806	GCG	213;212;212	G;C;G	194;173;188	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1927	1929	GGT	169;167;165	G;G;T	156;153;151	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1936	1938	GGC	163;161;161	G;G;C	146;143;143	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3914	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2382	163.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1954	1956	CCG	133;136;137	C,G;C,G;G	100,5;106,1;103	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5764	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3035	189.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1577	1579	CTG	216;219;219	C;T,C;G	194;203,1;201	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2202	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1783	122.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	317	319	GGC	175;175;175	G;G,T;C	160;156,1;158	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2202	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1783	122.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	499	499	C	147	C	138	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2814	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1444	193.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	894	894	T	271	T	252	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2814	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1444	193.2	1	SNP	p	G120K	0	.	.	358	360	GGT	621	623	GGT	227;226;229	G;G;T,C	202;203;200,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2814	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1444	193.2	1	SNP	p	A121N	0	.	.	361	363	GCC	624	626	GCC	221;224;224	G,A;C,G;C	198,1;199,1;201	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2814	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1444	193.2	1	SNP	p	A121D	0	.	.	361	363	GCC	624	626	GCC	221;224;224	G,A;C,G;C	198,1;199,1;201	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9972	rpoB	4179	4179	99.95	rpoB.l6.c17.ctg.1	4819	206.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1036	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	951	108.0	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	187;186;187	A;T;G	182;182;184	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
